Details for: JAMP GRANISETRON
Company: JAMP PHARMA CORPORATION
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
02472686 | JAMP GRANISETRON | GRANISETRON (GRANISETRON HYDROCHLORIDE) | 1 MG | TABLET | ORAL |
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
JAMP Granisetronis one of a group called antiemetics and it can only be obtained with a prescription from your doctor. JAMP Granisetron is intended to prevent nausea (feeling sick) and vomiting which may occur after you receive cancer chemotherapy or radiotherapy.
What it does
Cancer chemotherapies and radiation therapies are thought to cause the release of serotonin, a natural substance in the body. Serotonin can cause you to feel sick and to vomit. Granisetron, the active ingredient in JAMP Granisetron, will stop the action of serotonin and help prevent you from feeling sick and vomiting.
When it should not be used
- Do not take this medicine if you are allergic to granisetron or any of the ingredients JAMP Granisetron contains.
- If you are taking apomorphine.
What the medicinal ingredient is
Granisetron hydrochloride
What the non-medicinal ingredients are
Each tablet contains the following inactive ingredients: lactose anhydrous, microcrystalline cellulose, sodium starch glycolate, hydroxypropyl methylcellulose, magnesium stearate, and, polyvinyl alcohol, titanium dioxide, polyethylene glycol, and talc.
What dosage form it comes in
JAMP Granisetronare supplied in one strength:1 mg tablets.
Warnings and precautions
BEFORE you use JAMP Granisetron talk to your doctor or pharmacist if:
- You have any allergies to similar antiemetics such as dolasetron mesylate (Anzemet®) or ondansetron (Zofran®).
- You are pregnant, plan to become pregnant or are breastfeeding.
- You have liver problems
- You have a history of heart problems.
- You have galactose intolerance, lactase deficiency (lactose intolerance) or glucose-galactose absorption issues, since JAMP Granisetron contains lactose, which is a type of sugar.
- You have been told by a doctor that you have a blockage of your gut or if you have severe constipation, pain or swelling in your stomach.
- You are taking other medications, including drugs you can buy without a prescription and herbal products.
Interactions with this medication
As with most medicines, interactions with other drugs are possible. To avoid potentially life-threatening reactions, tell your healthcare professional about ALL the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines.
Proper use of this medication
This medicine is only for you, the person for whom the prescription
was written. Do not give this medication to others.
Usual adult dose:
Follow your doctor’s instructions about how often you should take
your medicine and how many tablets you should take. This information
is also on the label of the container of your medicine and if not, of if
you have any questions, you should consult your doctor or pharmacist.
Do not take more tablets or take your tablets more often than your
doctor prescribes.
Overdose:
In the event that you accidentally take more tablets than your doctor
prescribes, immediately contact your doctor, hospital emergency
department, or the nearest Poison Control Centre, even if you do not
feel ill.
Missed Dose:
If you forget to take a tablet at the time it should be taken, take the tablet as soon as you remember it was missed.
Side effects and what to do about them
If you experience an allergic reaction (e.g. shortness of breath, drop in blood pressure, skin lumps or hives), contact your doctor immediately. Do not take any more medicine unless instructed to do so by your doctor. You may experience headaches, constipation, weakness, sleepiness, diarrhea or abdominal pain while taking JAMP Granisetron. There is no need to stop the medicine but you should tell your doctor about these symptoms.
Symptom / effect | Talk with your doctor or pharmacist Only if severe | Talk with your doctor or pharmacist In all cases | Stop taking drug and seek immediate medical help |
---|---|---|---|
Rare | |||
Allergic reaction symptoms include swelling of the mouth, throat, difficulty in breathing, rash, hives, increased heart rate | ✔ | ||
Disturbance in heart rhythm dizziness, palpitations (fast, pounding or irregular heart beat), chest pain, fainting | ✔ | ||
Serotonin Syndrome
symptoms that may be
observed when JAMP
Granisetron is taken
with certain other
medications include:
|
✔ |
How to store
Store at room temperature 15°C -30°C.
The expiry date of this medicine is printed on the label. Do not use this
medicine after this date. Keep your medicine in a safe place out of the
reach and sight of children.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/healthcanada/services/drugs-health-products/medeffectcanada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (http://www.canada.ca/en/healthcanada/service/drugs -healthproducts/drugproducts/drug-product-database.html or by calling 1-866-399-9091
Jamp Pharma Corporation
1310 rue Nobel,
Boucherville, Québec,
Canada, J4B 5H3
Date of revision: January 13, 2020